On the heels of news reports that pharmaceutical companies reaped big profits over the past year marketing prescription drugs directly to television viewers, General Electric Medical Systems hit the airwaves hard during the recent Sydney Olympics with
On the heels of news reports that pharmaceutical companies reaped big profits over the past year marketing prescription drugs directly to television viewers, General Electric Medical Systems hit the airwaves hard during the recent Sydney Olympics with ads for expensive scanning hardware.
The ads were really directed at radiologists, said Brian S. Johnson, marketing communications manager for GE Medical Systems. A spot for the LightSpeed CT scanner made it clear that its operators were radiologists (even a patient in one of the spots was a radiologist), but the punch line could well have been aimed at the consumer:
Does your hospital have one? said the voiceover.
We wrestled with whether we should add that to see how the market would react to that bolder comment, Johnson said, but we tested it with customers and decided to run it.
Johnson said the rhetorical question was removed after its initial appearance, and subsequent LightSpeed commercials ran without it.
We were definitely very sensitive to that whole issue (of direct-to-consumer marketing), he said. The commercials were for GEMS, but were not funded or developed by GEMS. Corporate mainly wanted to target investors, shareholders, and decision-makers.
A couple of decades ago such direct-to-consumer (or patient) marketing would have been considered unethical, but now everyones doing it. Johnson said about half the TV commercials were for GEMS products such as LightSpeed, the Senographe digital mammography unit, and the Signa OpenSpeed MRI scanner, although their corporate parent was calling the shots. GE owns NBC, which broadcast the Sydney games in the U.S.
The company slogan is We bring good things to life, so they obviously looked to GEMS, and we benefited, he said.
GE Power Systems and GE Financial Systems commercials were also shown on the Olympics broadcasts and on the Sunday morning talk shows, he said.
Johnson said he did not have placement numbers for the commercials, which will be made available to customers for use in their home regions.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.